Grow your business safely with SOFIPROTEOL CAPITAL I

All the information you need about SOFIPROTEOL CAPITAL I to develop and secure your business in France

S HOME > CORPORATES > SOFIPROTEOL CAPITAL I > BALANCE SHEET ( 2022-09-14)

THE LIST OF BALANCE SHEET : SOFIPROTEOL CAPITAL I

CORPORATEBOBACCESTABLISHMENTSMANAGERSFINANCE
Deposit Confidentiality closing date document
2023-07-07 Public 2022-12-31 Complete
2022-09-14 Public 2021-12-31 Complete
2021-08-26 Public 2020-12-31 Complete
2020-08-06 Public 2019-12-31 Complete
2019-07-02 Public 2018-12-31 Complete
NameSOFIPROTEOL CAPITAL I
Siren834020638
Closing2021-12-31
Registry code 7501
Registration number 120123
Management number2017B29008
Activity code 6430Z
Closing date n-12020-12-31
Duration Fiscal year 12
Duration Fiscal year n-112
Filing date2022-09-14
Modification00 Annual accounts entered without anomaly
Balance sheet typeC : Complete
Currency codeEUR
ConfidentialityPublic
Address75008 PARIS
1 - Assets (balance sheet)Gross amount year NAmortization year NNet year NNet year N-1
AA Uncalled Subscribed Capital 43 200 000.00 43 200 000.00 43 200 000.00
AB Establishment Expenses 250 104.00 191 596.00 58 508.00 250 104.00
BD Other fixed assets 62 329 385.00 62 329 385.00 62 329 385.00
BJ TOTAL (I) 78 698 064.00 191 596.00 78 506 468.00 78 698 064.00
BZ Other receivables 2 478 000.00 2 478 000.00 2 478 000.00
CF Cash and cash equivalents 379 765.00 379 765.00 379 765.00
CJ TOTAL (II) 2 857 765.00 2 857 765.00 2 857 765.00
CO Grand total (0 to V) 124 755 829.00 191 596.00 124 564 233.00 124 755 829.00
CU Other investments 16 118 575.00 16 118 575.00 16 118 575.00
2 - Liabilities (balance sheet)Amount year NAmount year N-1
DA Share or individual capital 120 001 000.00 120 001 000.00 120 001 000.00
DH Retained earnings 4 645 964.00 -883 484.00 4 645 964.00
DI RESULTS FOR THE YEAR (Profit or Loss) -385 740.00 5 529 448.00 -385 740.00
DK Regulated provisions 25 009.00 25 009.00
DL TOTAL (I) 124 286 234.00 124 646 964.00 124 286 234.00
DX Trade payables and related accounts 278 000.00 7 656.00 278 000.00
EC TOTAL (IV) 278 000.00 7 656.00 278 000.00
EE Grand total (I to V) 124 564 233.00 124 654 620.00 124 564 233.00
3 - Income statementAmount France year NAmount Export year NTotal year NTotal year N-1
FQ Other income 8 500.00
FR Total operating income (I) 8 500.00
FW Other purchases and external expenses 1 393 334.00
GA Operating Expenses - Depreciation and Amortization 50 021.00
GF Total Operating Expenses (II) 1 443 355.00
GG - OPERATING RESULT (I - II) -1 434 855.00
GL Other interest and similar income 551 262.00
GP Total financial income (V) 1 074 124.00
GV - FINANCIAL INCOME (V - VI) 1 074 124.00
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) -360 731.00
4 - Income statement (continued)Amount year NAmount year N-1
HB Exceptional income from capital transactions 11 179 981.00
HD Total exceptional income (VII) 11 179 981.00
HF Exceptional expenses on capital transactions 5 218 854.00
HG Exceptional depreciation and provisions 25 009.00 25 009.00
HH Total exceptional expenses (VIII) 25 009.00 5 218 854.00 25 009.00
HI - EXCEPTIONAL RESULT (VII - VIII) -25 009.00 5 961 128.00 -25 009.00
HL TOTAL REVENUE (I + III + V + VII) 1 082 624.00 11 817 312.00 1 082 624.00
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) 1 468 364.00 6 287 864.00 1 468 364.00
HN PROFIT OR LOSS (Total revenue - Total expenses) -385 740.00 5 529 448.00 -385 740.00
5 - Fixed assets increase - decreaseGross value at beginning of year - Item by itemRevaluation - DisposalsAcquisition - Gross value at year-end
0G ACQUISITIONS Total General Total 52 162 861.00 26 591 373.00 52 162 861.00
CZ ACQUISITIONS: Establishment, Development, or Research Expenses 250 104.00 250 104.00
I2 DECREASES Loans and Financial Fixed Assets 56 169.00
I3 DECREASES Total Financial Fixed Assets 56 169.00 78 447 960.00
I4 DECREASES Grand Total 56 169.00 78 698 064.00
IN DECREASES Start-up, development, or research expenses 250 104.00
LQ ACQUISITIONS Total Financial Fixed Assets 51 912 757.00 26 591 373.00 51 912 757.00
6 - Depreciation Amount at beginning of yearIncrease: allocation for the yearDiminution repriseYear-end amount
0N DEPRECIATION Grand Total 141 574.00 50 021.00 141 574.00
CY DEPRECIATION Start-up, development, or research expenses 141 574.00 50 021.00 141 574.00
8 - Receivables and payablesGross amountAmount within 1 yearAmount 1 to 5 yearsAmount more than 5 years
8B Suppliers and Related Accounts 278 000.00 278 000.00 278 000.00
VC Group and associates 2 478 000.00 2 478 000.00 2 478 000.00
VT TOTAL – STATEMENT OF RECEIVABLES 2 478 000.00 2 478 000.00 2 478 000.00
VY TOTAL – STATEMENT OF LIABILITIES 278 000.00 278 000.00 278 000.00

all companies in France

Complete and comprehensive database.